open and closed source software (ClinRisk Ltd)
Structured Review
Open And Closed Source Software, supplied by ClinRisk Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/open+source+design+software/open+and+closed+source+software/pm36261855-263-5-0
Average 90 stars, based on 1 article reviews
Images
Related Articles
Software:Article Title: Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people. Article Snippet: JH-C is co-owner of ClinRisk Ltd and was a paid director until June 2019. .. ClinRisk Ltd develops open and Article Title: External validation of the QCovid 2 and 3 risk prediction algorithms for risk of COVID-19 hospitalisation and mortality in adults: a national cohort study in Scotland. Article Snippet: Competing interests JH- C reports grants from MRC, grants from Wellcome Trust, grants from NIHR, during the conduct of the study; JH- C is a founder and shareholder of ClinRisk and was its medical director until 31 May 2019. .. ClinRisk produces open and Article Title: Effectiveness and safety of COVID-19 vaccination in people with blood cancer. Article Snippet: .. JHC is founder and was shareholder until 9 Aug 2023 of ClinRisk Ltd, which produces open and Article Title: Importance of accurate and accessible recording of healthcare contacts in mental health. Article Snippet: .. JHC was also a paid director of ClinRisk Ltd. which produces open and other:Article Title: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England Article Snippet: J.H.C. is founder and was shareholder until 9 Article Title: Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study. Article Snippet: Article Title: Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study. Article Snippet: Article Title: Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study Article Snippet: |
